Dr Amanda Francisco
Dr Francisco's obtained a BSc in Nutrition and an MSc and PhD in Biological Sciences, both from the Federal University of Ouro Preto in Brazil. In 2012, she was awarded a scholarship from The Brazilian National Council for Scientific and Technological Development to work on the Trypanosoma cruzi heart pathology in John Kelly' lab at LSHTM where she undertook this post-doctoral work for 2 years. In 2014, Amanda started to work at LSHTM funded by Drugs for Neglected Diseases initiative (DNDi). DNDi is a non-profit research and development organization that is developing new treatments for neglected diseases. Currently, Amanda is working with drug discovery for DNDi, GSK, Novartis and others using the bioluminescence in vivo image system for T. cruzi and on the pathogenesis of Chronic Chagasic Cardiomyopathy (CCC).